The effect of erythropoietin on autologous stem cell-mediated bone regeneration

Biomaterials

Volumn 34, Issue 30, 2013, Pages 7364-7371

  Nair, Ashwin M ^a   Tsai, Yi Ting ^a   Shah, Krishna M ^a   Shen, Jinhui ^a   Weng, Hong ^a   Zhou, Jun ^a   Sun, Xiankai ^b   Saxena, Ramesh ^b   Borrelli, Joseph ^c   Tang, Liping ^a  

^a The University of Texas at Arlington   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Arlington Memorial Hospital   (United States)

Author keywords

Autologous stem cells; Bone morphogenetic protein 2; Bone tissue engineering; Erythropoietin; Scaffold; Stromal derived factor 1

Indexed keywords

BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE ENGINEERING; ERYTHROPOIETIN (EPO); FLUORESCENT IMAGING; HISTOLOGICAL ANALYSIS; ISOLATION AND CULTURE; MESENCHYMAL STEM CELL; OSTEOGENIC DIFFERENTIATION;

BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CELL CULTURE; COMPUTERIZED TOMOGRAPHY; DEFECTS; FLOWCHARTING; SCAFFOLDS; STEM CELLS;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 2; ERYTHROPOIETIN; OSTEOCALCIN; OSTEOPONTIN; STROMAL CELL DERIVED FACTOR 1ALPHA; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE DEFECT; BONE DEVELOPMENT; BONE GROWTH; BONE IMPLANT; BONE MASS; BONE REGENERATION; CALVARIA; CELL COUNT; CELL DIFFERENTIATION; CHEMOTAXIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXPLANT; FLUORESCENCE IMAGING; HISTOLOGY; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MICRO-COMPUTED TOMOGRAPHY; MICROBUBBLE; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING;

AUTOLOGOUS STEM CELLS; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE ENGINEERING; ERYTHROPOIETIN; SCAFFOLD; STROMAL DERIVED FACTOR-1Α;

ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOKINES; CHEMOTAXIS; ERYTHROPOIETIN; IMMUNOHISTOCHEMISTRY; IMPLANTS, EXPERIMENTAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; OSTEOGENESIS; SKULL; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS; X-RAY MICROTOMOGRAPHY;

MURINAE;

EID: 84880513358     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.031     Document Type: Article

References (63)

1. Betz R.R. Limitations of autograft and allograft: new synthetic solutions. Orthopedics 2002, 25:s561-s570.
2. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
3. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. JCell Physiol 2007, 213:341-347.
4. Meinel L., Karageorgiou V., Fajardo R., Snyder B., Shinde-Patil V., Zichner L., et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 2004, 32:112-122.
5. Meinel L., Karageorgiou V., Hofmann S., Fajardo R., Snyder B., Li C., et al. Engineering bone-like tissue invitro using human bone marrow stem cells and silk scaffolds. JBiomed Mater Res A 2004, 71:25-34.
6. Schneider R.K., Neuss S., Knuchel R., Perez-Bouza A. Mesenchymal stem cells for bone tissue engineering. Pathologe 2010, 31(Suppl.2):138-146.
7. Seong J.M., Kim B.C., Park J.H., Kwon I.K., Mantalaris A., Hwang Y.S. Stem cells in bone tissue engineering. Biomed Mater 2010, 5:062001.
8. Diao H., Wang J., Shen C., Xia S., Guo T., Dong L., et al. Improved cartilage regeneration utilizing mesenchymal stem cells in TGF-beta1 gene-activated scaffolds. Tissue Eng Part A 2009, 15:2687-2698.
9. Jukes J.M., Both S.K., Leusink A., Sterk L.M., van Blitterswijk C.A., de Boer J. Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci U S A 2008, 105:6840-6845.
10. Shin M., Yoshimoto H., Vacanti J.P. Invivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng 2004, 10:33-41.
11. Wayne J.S., McDowell C.L., Shields K.J., Tuan R.S. Invivo response of polylactic acid-alginate scaffolds and bone marrow-derived cells for cartilage tissue engineering. Tissue Eng 2005, 11:953-963.
12. Jang S., Cho H.H., Cho Y.B., Park J.S., Jeong H.S. Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol 2010, 11:25.
13. Romanov Y.A., Svintsitskaya V.A., Smirnov V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003, 21:105-110.
14. Xu B., Zhang J., Brewer E., Tu Q., Yu L., Tang J., et al. Osterix enhances BMSC-associated osseointegration of implants. JDent Res 2009, 88:1003-1007.
15. Nair A., Shen J., Lotfi P., Ko C.Y., Zhang C.C., Tang L. Biomaterial implants mediate autologous stem cell recruitment in mice. Acta Biomater 2011, 7:3887-3895.
16. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. JCell Physiol 1998, 176:57-66.
17. Ries C., Egea V., Karow M., Kolb H., Jochum M., Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007, 109:4055-4063.
18. Rojas M., Xu J., Woods C.R., Mora A.L., Spears W., Roman J., et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005, 33:145-152.
19. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. Ahighly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). JExp Med 1996, 184:1101-1109.
20. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol 2002, 23:403-408.
21. Wengner A.M., Pitchford S.C., Furze R.C., Rankin S.M. The coordinated action of G-CSF and ELR+CXC chemokines in neutrophil mobilization during acute inflammation. Blood 2008, 111:42-49.
22. Wodnar-Filipowicz A., Heusser C.H., Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989, 339:150-152.
23. Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.Y., Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010, 31:3997-4008.
24. Kato S., Amano H., Ito Y., Eshima K., Aoyama N., Tamaki H., et al. Effect of erythropoietin on angiogenesis with the increased adhesion of platelets to the microvessels in the hind-limb ischemia model in mice. JPharmacol Sci 2010, 112:167-175.
25. Kertesz N., Wu J., Chen T.H., Sucov H.M., Wu H. The role of erythropoietin in regulating angiogenesis. Dev Biol 2004, 276:101-110.
26. Muller-Ehmsen J., Schmidt A., Krausgrill B., Schwinger R.H., Bloch W. Role of erythropoietin for angiogenesis and vasculogenesis: from embryonic development through adulthood. Am J Physiol Heart Circ Physiol 2006, 290:H331-H340.
27. Liu N., Tian J., Wang W., Cheng J., Hu D., Zhang J. Effect and mechanism of erythropoietin on mesenchymal stem cell proliferation invitro under the acute kidney injury microenvironment. Exp Biol Med (Maywood) 2011, 236:1093-1099.
28. Copland I.B., Jolicoeur E.M., Gillis M.A., Cuerquis J., Eliopoulos N., Annabi B., et al. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. Cardiovasc Res 2008, 79:405-415.
29. Patel Z.S., Young S., Tabata Y., Jansen J.A., Wong M.E., Mikos A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43:931-940.
30. Young S., Patel Z.S., Kretlow J.D., Murphy M.B., Mountziaris P.M., Baggett L.S., et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 2009, 15:2347-2362.
31. Shiozawa Y., Jung Y., Ziegler A.M., Pedersen E.A., Wang J., Wang Z., et al. Erythropoietin couples hematopoiesis with bone formation. PLoS One 2010, 5:e10853.
32. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). JTissue Eng Regen Med 2008, 2:81-96.
33. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). JTissue Eng Regen Med 2008, 2:1-13.
34. Nair A., Thevenot P., Dey J., Shen J., Sun M.W., Yang J., et al. Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods 2010, 16:23-32.
35. Fiorina P., Jurewicz M., Augello A., Vergani A., Dada S., La Rosa S., et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. JImmunol 2009, 183:993-1004.
36. Kretlow J.D., Jin Y.Q., Liu W., Zhang W.J., Hong T.H., Zhou G., et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008, 9:60.
37. Thevenot P., Nair A., Dey J., Yang J., Tang L. Method to analyze three-dimensional cell distribution and infiltration in degradable scaffolds. Tissue Eng Part C Methods 2008, 14:319-331.
38. Zhao Z., Wang Z., Ge C., Krebsbach P., Franceschi R.T. Healing cranial defects with AdRunx2-transduced marrow stromal cells. JDent Res 2007, 86:1207-1211.
39. Karageorgiou V., Tomkins M., Fajardo R., Meinel L., Snyder B., Wade K., et al. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 invitro and invivo. JBiomed Mater Res A 2006, 78:324-334.
40. Burgess A., Vigneron S., Brioudes E., Labbe J.C., Lorca T., Castro A. Loss of human greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A 2010, 107:12564-12569.
41. Gavet O., Pines J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell 2010, 18:533-543.
42. Potapova T.A., Sivakumar S., Flynn J.N., Li R., Gorbsky G.J. Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Mol Biol Cell 2011, 22:1191-1206.
43. Nissen L., Chingwaru W., Sgorbati B., Biavati B., Cencic A. Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: a functional study in the small intestinal cell model. Int J Food Microbiol 2009, 135:288-294.
44. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
45. da Silva Meirelles L., Caplan A.I., Nardi N.B. In search of the invivo identity of mesenchymal stem cells. Stem Cells 2008, 26:2287-2299.
46. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
47. Meirelles Lda S., Fontes A.M., Covas D.T., Caplan A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009, 20:419-427.
48. Prockop D.J., Olson S.D. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 2007, 109:3147-3151.
49. Covas D.T., Panepucci R.A., Fontes A.M., Silva W.A., Orellana M.D., Freitas M.C., et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 2008, 36:642-654.
50. Gronthos S., Graves S.E., Ohta S., Simmons P.J. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994, 84:4164-4173.
51. Gronthos S., Zannettino A.C., Hay S.J., Shi S., Graves S.E., Kortesidis A., et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. JCell Sci 2003, 116:1827-1835.
52. Lin G., Liu G., Banie L., Wang G., Ning H., Lue T.F., et al. Tissue distribution of mesenchymal stem cell marker Stro-1. Stem Cells Dev 2011, 20:1747-1752.
53. Shi S., Gronthos S., Chen S., Reddi A., Counter C.M., Robey P.G., et al. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 2002, 20:587-591.
54. Zwezdaryk K.J., Coffelt S.B., Figueroa Y.G., Liu J., Phinney D.G., LaMarca H.L., et al. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Exp Hematol 2007, 35:640-652.
55. Burger D., Lei M., Geoghegan-Morphet N., Lu X., Xenocostas A., Feng Q. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 2006, 72:51-59.
56. Mudalagiri N.R., Mocanu M.M., Di Salvo C., Kolvekar S., Hayward M., Yap J., et al. Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activation. Br J Pharmacol 2008, 153:50-56.
57. von Lindern M., Parren-van Amelsvoort M., van Dijk T., Deiner E., van den Akker E., van Emst-de Vries S., et al. Protein kinase C alpha controls erythropoietin receptor signaling. JBiol Chem 2000, 275:34719-34727.
58. Holstein J.H., Menger M.D., Scheuer C., Meier C., Culemann U., Wirbel R.J., et al. Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing. Life Sci 2007, 80:893-900.
59. Chen C.L., Chou K.J., Lee P.T., Chen Y.S., Chang T.Y., Hsu C.Y., et al. Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines. Exp Cell Res 2010, 316:1109-1118.
60. Chen G., Deng C., Li Y.P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012, 8:272-288.
61. Javed A., Bae J.S., Afzal F., Gutierrez S., Pratap J., Zaidi S.K., et al. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. JBiol Chem 2008, 283:8412-8422.
62. Washio A., Kitamura C., Morotomi T., Terashita M., Nishihara T. Possible involvement of Smad signaling pathways in induction of odontoblastic properties in KN-3 cells by bone morphogenetic protein-2: a growth factor to induce dentin regeneration. Int J Dent 2012, 2012:258469.
63. Yu B., Zhao X., Yang C., Crane J., Xian L., Lu W., et al. PTH induces differentiation of mesenchymal stem cells by enhancing BMP signaling. JBone Miner Res 2012, 27:2001-2014.